![](https://d3ilqtpdwi981i.cloudfront.net/QHlHfAVnSnlOgrBRr06Y0PUDWeU=/0x6:298x391/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/4a/23/f6/4a23f622-95e8-476a-96c4-3fffe5a96371/AJCO.jpeg)
Article
Lenalidomide for Second-line Treatment of Advanced Hepatocellular Cancer: a Brown University Oncology Group Phase II Study.
American Journal of Clinical Oncology
(2015)
Disciplines
Publication Date
January 2, 2015
DOI
10.1097/COC.0b013e3182868c66
Citation Information
Howard Safran, Kevin P. Charpentier, Andreas Kaubisch, Kalyan Mantripragada, et al.. "Lenalidomide for Second-line Treatment of Advanced Hepatocellular Cancer: a Brown University Oncology Group Phase II Study." American Journal of Clinical Oncology Vol. 38 Iss. 1 (2015) p. 1 - 4 Available at: http://works.bepress.com/santiago-aparo/5/